Published in Mol Biochem Parasitol on March 01, 1983
A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med (1990) 4.90
A newly discovered protein export machine in malaria parasites. Nature (2009) 2.79
Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum. J Exp Med (1985) 2.15
PTEX component HSP101 mediates export of diverse malaria effectors into host erythrocytes. Nature (2014) 1.82
Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene. Proc Natl Acad Sci U S A (1986) 1.77
Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level. EMBO J (1985) 1.69
A naturally occurring gene encoding the major surface antigen precursor p190 of Plasmodium falciparum lacks tripeptide repeats. EMBO J (1987) 1.58
Cloning and characterisation of the rRNA genes from the human malaria parasite Plasmodium falciparum. Nucleic Acids Res (1983) 1.47
Formation of the food vacuole in Plasmodium falciparum: a potential role for the 19 kDa fragment of merozoite surface protein 1 (MSP1(19)). PLoS One (2008) 1.18
The gene for an exported antigen of the malaria parasite Plasmodium falciparum cloned and expressed in Escherichia coli. Nucleic Acids Res (1985) 1.18
A blood stage antigen of Plasmodium falciparum shares determinants with the sporozoite coat protein. Proc Natl Acad Sci U S A (1985) 1.17
Major surface antigen p190 of Plasmodium falciparum: detection of common epitopes present in a variety of plasmodia isolates. EMBO J (1988) 1.17
Third form of the precursor to the major merozoite surface antigens of Plasmodium falciparum. Mol Cell Biol (1988) 1.16
Demonstration of antigenic polymorphism in Plasmodium vivax malaria with a panel of 30 monoclonal antibodies. Infect Immun (1987) 1.03
Spatial association with PTEX complexes defines regions for effector export into Plasmodium falciparum-infected erythrocytes. Nat Commun (2013) 0.98
In vitro inhibition of multiplication of Babesia bigemina by using monoclonal antibodies. J Clin Microbiol (1991) 0.97
Initial extracellular forms of Plasmodium falciparum: their ultrastructure and their definition with monoclonal antibodies. Proc Natl Acad Sci U S A (1991) 0.91
A conserved region of the MSP-1 surface protein of Plasmodium falciparum contains a recognition sequence for erythrocyte spectrin. EMBO J (1993) 0.90
Human-human hybridomas secreting monoclonal antibodies to the Mr 195,000 Plasmodium falciparum blood stage antigen. J Exp Med (1986) 0.89
Inhibition of Plasmodium falciparum growth by IgG antibody produced by human lymphocytes transformed with Epstein-Barr virus. Clin Exp Immunol (1986) 0.89
Identification of a cDNA clone encoding a mature blood stage antigen of Plasmodium falciparum by immunization of mice with bacterial lysates. EMBO J (1984) 0.87
Initiation of translation at a UAG stop codon in the aldolase gene of Plasmodium falciparum. EMBO J (1990) 0.86
Molecular characterisation and stage-specific expression of proliferating cell nuclear antigen (PCNA) from the malarial parasite, Plasmodium falciparum. Nucleic Acids Res (1993) 0.83
Stage-specific and species-specific antigens of Plasmodium vivax and Plasmodium ovale defined by monoclonal antibodies. Infect Immun (1986) 0.78
The Plasmodium falciparum rhoptry protein RhopH3 plays essential roles in host cell invasion and nutrient uptake. Elife (2017) 0.76
The chaperonin TRiC forms an oligomeric complex in the malaria parasite cytosol. Cell Microbiol (2017) 0.75
Plasmodium berghei EXP-1 interacts with host Apolipoprotein H during Plasmodium liver-stage development. Proc Natl Acad Sci U S A (2017) 0.75
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Confidential inquiry into quality of care before admission to intensive care. BMJ (1998) 11.32
The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53
Genetic analysis of the human malaria parasite Plasmodium falciparum. Science (1987) 6.48
Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci U S A (1988) 5.92
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia (2009) 4.91
A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
New controlling element in the Lac operon of E. coli. Nature (1968) 4.63
Radioimmunoassay of human serum thyrotrophin. Br Med J (1971) 4.59
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia (2011) 4.47
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
Liver from bone marrow in humans. Hepatology (2000) 4.10
Effect of counselling on the psychiatric morbidity associated with mastectomy. Br Med J (1980) 4.03
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (2000) 3.89
Mutational alteration of the maximal level of Lac operon expression. Cold Spring Harb Symp Quant Biol (1966) 3.71
Relapsing illness due to Rochalimaea henselae in immunocompetent hosts: implication for therapy and new epidemiological associations. Clin Infect Dis (1992) 3.61
Hypertension treated by salt restriction. Lancet (1978) 3.59
Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency. Lancet (1992) 3.45
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Grades of hypothyroidism. Br Med J (1973) 3.30
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84
F-prime factor formation in E. coli K12. Genet Res (1966) 2.80
High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J Infect Dis (2001) 2.78
Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature (1984) 2.74
Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70
Hopping hotspots: global shifts in marine biodiversity. Science (2008) 2.68
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol (2000) 2.62
Hybrid formation between African trypanosomes during cyclical transmission. Nature (1986) 2.61
Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet (1975) 2.57
A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum. Cell (1987) 2.53
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Homologous recombination within subtelomeric repeat sequences generates chromosome size polymorphisms in P. falciparum. Cell (1988) 2.46
Cross-species interactions between malaria parasites in humans. Science (2000) 2.43
Bromocriptine therapy in acromegaly. Lancet (1975) 2.42
Episomes. Annu Rev Microbiol (1967) 2.36
Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans R Soc Trop Med Hyg (2001) 2.34
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Treatment of hypothyroidism: a reappraisal of thyroxine therapy. Br Med J (1973) 2.30
The establishment of genomic DNA libraries for the human malaria parasite Plasmodium falciparum and identification of individual clones by hybridisation. Mol Biochem Parasitol (1982) 2.28
Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A (1999) 2.25
Identification of a single promoter in E. coli for rplJ, rplL and rpoBC. Nature (1978) 2.22
Anxiety caused by abnormal result of cervical smear test: a controlled trial. BMJ (1990) 2.22
Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events. Rheumatology (Oxford) (2005) 2.11
Genetic diversity and dynamics of plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology (2000) 2.10
Antigenic diversity in the human malaria parasite Plasmodium falciparum. Science (1982) 2.09
Human eosinophils express transforming growth factor alpha. J Exp Med (1990) 2.04
Suspected adverse reactions, 2009. Vet Rec (2010) 2.04
Mapping of transcription initiation and termination signals on Xenopus laevis ribosomal DNA. Proc Natl Acad Sci U S A (1982) 1.99
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. Br Med J (1980) 1.95
The efficacy of a semirigid ankle stabilizer to reduce acute ankle injuries in basketball. A randomized clinical study at West Point. Am J Sports Med (1994) 1.94
Clinical pathology testing recommendations for nonclinical toxicity and safety studies. AACC-DACC/ASVCP Joint Task Force. Toxicol Pathol (1992) 1.94
Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans R Soc Trop Med Hyg (1998) 1.91
Venous malformations in the orbit. Br J Ophthalmol (1971) 1.90
Aggregative adherence fimbria I expression in enteroaggregative Escherichia coli requires two unlinked plasmid regions. Infect Immun (1993) 1.89
Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86
Tobacco and the risk of acute leukaemia in adults. Br J Cancer (1999) 1.85
A clinical and immunological study of Netherton's syndrome. Br J Dermatol (1994) 1.83
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Letter: Complication of proximal gastric vagotomy. Br Med J (1974) 1.82
The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased. Br J Clin Pharmacol (1976) 1.80
Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man. Br Med J (1970) 1.79
Genetic structure and dynamics of Plasmodium falciparum infections in the Kilombero region of Tanzania. Trans R Soc Trop Med Hyg (1999) 1.79
Effusions into body cavities in hypothyroidism. Lancet (1975) 1.77
Corneal and intra-ocular infection due to Fusarium solani. Trans Ophthalmol Soc U K (1970) 1.77
Evidence for a lambda transducing phage carrying the genes for the beta and beta' subunits of Escherichia coli RNA polymerase. Mol Gen Genet (1974) 1.75
Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am J Trop Med Hyg (1998) 1.75
Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi--a rodent malaria model. Parasite Immunol (1990) 1.74
Random mating in a natural population of the malaria parasite Plasmodium falciparum. Parasitology (1994) 1.73
Septicemia in patients with an endocardial pacemaker. Am J Cardiol (1979) 1.73
Serum-thyrotropin levels after subtotal thyroidectomy for Graves' disease. Lancet (1971) 1.73
Molecular karyotype of Plasmodium falciparum: conserved linkage groups and expendable histidine-rich protein genes. Proc Natl Acad Sci U S A (1987) 1.72
Enzyme typing of Plasmodium falciparum from African and some other Old World countries. Trans R Soc Trop Med Hyg (1981) 1.72
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70
Management of treatment-emergent peripheral neuropathy in multiple myeloma. Leukemia (2011) 1.70
Genetic studies on Plasmodium chabaudi: recombination between enzyme markers. Parasitology (1975) 1.69
Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level. EMBO J (1985) 1.69
Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol Cell Biol (1991) 1.68
Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med (1986) 1.68
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
A new method for selecting RNA polymerase mutants. J Mol Biol (1970) 1.68
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Population structure of Plasmodium falciparum in villages with different malaria endemicity in east Africa. Am J Trop Med Hyg (1997) 1.65
Effects of bromocriptine on pituitary tumour size. Br Med J (1979) 1.64
Evidence for diploidy and mating in trypanosomes. Nature (1980) 1.63
Characterization of a R plasmid-associated, trimethoprim-resistant dihydrofolate reductase and determination of the nucleotide sequence of the reductase gene. Nucleic Acids Res (1981) 1.63
Malignant alienation. Dangers for patients who are hard to like. Br J Psychiatry (1994) 1.63
Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum. Trans R Soc Trop Med Hyg (1984) 1.63